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Cartilage hair hypoplasia with cutaneous lymphomatoid 
granulomatosis 
D. Sathishkumar,1 J. E. Gach1, M. Ogboli1, M. Desai2, T. Cole3, W. Högler4, J. Motwani5, A. Norton5, B. 
Morland6 and I. Colmenero7 
Departments of 1Dermatology, 2Respiratory Medicine, 4Endocrinology and Diabetes, 5Haematology, 6Oncology, and 7Pathology, 
Birmingham Children’s Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK; 3Department of 
Clinical Genetics, Birmingham Women’s Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, 
UK 
Summary 
Cartilage–hair hypoplasia (CHH) is an autosomal recessive chondrodysplasia characterized by short-
stature, sparse hair and impaired cellular immunity. We describe a young girl who was diagnosed with CHH 
based on the findings of recurrent infections, short stature with metaphyseal chondrodysplasia, and a 
confirmed bi-allelic RMRP gene mutation. At 13 years, the patient developed an Epstein–Barr Virus (EBV)-
driven lymphoproliferative disorder involving the lung, which responded partially to chemotherapy. 
Simultaneously, she developed multiple indurated plaques involving the face, which had histological 
findings of granulomatous inflammation and EBV-associated low-grade lymphomatoid granulomatosis. The 
patient received a matched unrelated peripheral blood stem cell transplant at 15 years and her 
immunological parameters and skin lesions improved. Lymphomatoid forms of granulomatosis and 
cutaneous EBV-associated malignancies have not been previously described in CHH. This case highlights 
the possibility of EBV-associated cutaneous malignancy in CHH. 
 
Cartilage–hair hypoplasia (CHH) is a rare autosomal recessive metaphyseal chondrodysplasia caused by 
mutations of the untranslated RMRP gene, which encodes for the RNA component of the mitochondrial 
RNA processing (RMRP) endoribonuclease. CHH is characterized by short stature with other skeletal 
abnormalities, fine sparse hair, and abnormal immune system function (immune deficiency) that can lead to 
recurrent infections.1 Granulomatous inflammation is described in patients with various forms of primary 
immunodeficiencies including CHH; however, lymphomatoid granulomatosis (LG) has not been reported in 
patients with CHH. LG is a rare Epstein–Barr Virus (EBV)-driven B-cell lymphoproliferative disorder that 
most frequently involves the lungs but may also involve the skin and central nervous system. LG is graded 
from 1 to 3 according to the number of EBV-positive cells in a high-power field (HPF).2 We describe a girl 
with CHH and an EBV-driven lymphoproliferative disorder involving the skin and the lungs. 
Report 
A 13-year-old girl with CHH presented with a 4-month history of asymptomatic purple plaques and nodules 
on her nose, upper lips and chin (Fig. 1a b). She had been born healthy to unrelated white parents and 
there was no significant family history. The patient developed recurrent infections in her first year of life and 
severe chicken pox at the age of 7 years, resulting in varicella pneumonitis and bronchiectasis.  
When the patient was 11 years old, the diagnosis of CHH was suggested as she had recurrent severe 
chest infections, short stature (height persistently < 0.4 percentile) and the radiological finding of 
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metaphyseal chondrodysplasia in the long bones. Immunological studies revealed a lower than normal 
CD8 count for age, indicating T-cell lymphopenia: T cell CD3+: 0.56 × 109/L (range 0.8–3.5 × 109/L), 
CD3+CD4+: 0.46 × 109/L (0.4–2.1 × 109/L), CD3+CD8+: 0.08 × 109/L (0.2–1.2 × 109/L); B cell CD19+: 
0.18 × 109/L (0.2–0.6 × 109/L); and natural kiler cell CD16+CD56+: 0.15 × 109/L (0.07–1.2 × 109/L). In 
addition, she had intermittent neutropenia and immunoglobulins were normal. Genetic analysis revealed a 
compound heterozygous mutation, g(4C>T) and g(242A>G), in the RNAse mitochondrial RNA processing 
endoribonuclease gene (RMRP), confirming the diagnosis of CHH. On dermatological examination, the rest 
of her skin, hair and nails were normal. Skin biopsy from a facial lesion showed granulomatous dermatitis 
composed of lymphocytes and histiocytes with a few epithelioid granulomas. The lesions did not respond to 
superpotent topical steroids (clobetasol proprionate cream), and the patient was lost to dermatological 
follow-up. 
At the age of 14 years, multiple progressive round lesions in both lungs were noted on a computed 
tomography scan of the thorax and a biopsy of the right anterior lung mass showed EBV-driven diffuse 
large B-cell lymphoma (Fig. 2). She received treatment with modified lymphoma protocol (GRAB) with 
rituximab for 6 months. An initial response to chemotherapy was seen, but residual lung lesions remained 
at the end of treatment, which on further resection showed complete necrosis negative for EBV. The patient 
was re-referred to dermatology at 14 years as the skin lesions continued to increase despite 
chemotherapy.  
At presentation, the patient was found to have extensive purple plaques and nodules infiltrating deep 
into the subcutis on her nose, nasolabial folds, cheeks, upper lip and chin (Fig. 1c,d). Histological 
examination of a skin biopsy from a chin nodule revealed a dense, diffuse, angiocentric and angioinvasive 
chronic inflammatory infiltrate of the reticular dermis, mainly composed of mature lymphocytes and 
histiocytes with some epithelioid granulomas and Langhans type giant cells. Scattered larger atypical 
lymphoid cells were also noted (Fig. 3). In situ hybridization (ISH) for EBV-encoded RNA (EBER) (Fig. 3) 
showed positivity only in the large cells (< 5 EBV-positive lymphoid cells per HPF).Retrospective ISH 
studies with EBER of the original skin biopsy showed similar findings. Based on these features, the 
diagnosis of grade 1 EBV-driven LG of the skin was made in this patient with known CHH previously 
treated for grade 3 pulmonary LG.  
At 15 years, the patient underwent a successful matched unrelated peripheral blood stem cell transplant 
for the management of immunodeficiency, which also led to marked improvement in her skin lesions. (Fig. 
1e, f) 
To our knowledge, his is the first report of cutaneous LG described in CHH, reinforcing that EBV-
associated granulomas should be considered in cutaneous lesions of patients with immunodeficiency. CHH 
is a primary immunodeﬁciency syndrome with impairment of cellular immunity in > 85% of patients, and in a 
minority humoral immunity can also be affected. Mortality is high in patients with CHH because of their 
defective immunity and frequent infections. Patients with CHH also have a seven-fold increased risk of 
cancer.1 The most frequent cancer diagnoses have been non-Hodgkin lymphoma of B-cell origin and basal 
cell carcinoma.3 
LG is a rare EBV-driven B-cell lymphoproliferative disorder with reactive T cells, primarily involving the 
lung, but also the skin, kidney and brain. LG usually occurs in middle-aged adults and is only rarely seen in 
childhood.2 In a review of LG in 49 children aged 0–18 years, only 11 had cutaneous involvement. LG 
mostly occurs in immunocompromised patients, indicating that immunodeficiency plays a role in its 
aetiology.4 The classic histopathological features include angiocentric and angiodestructive lymphoid 
infiltrate with EBV-positive large atypical B cells and a prominent population of small reactive T cells and 
necrosis.2 
Granulomatous inflammation has been described in patients with immunodeficiencies and is thought to 
be a manifestation of immune dysregulation. Tacke et al. found epithelioid granulomas in 4 of their 21 
patients with CHH.5 One of the four patients showed positivity for ISH with EBER within one skin biopsy 
specimen; however, the EBV screening before and after this biopsy were all negative, and this finding was 
deemed coincidental and unrelated to the pathogenesis of granulomas. Three of these four patients had 
significant improvement after initiation of treatment with anti-tumour necrosis factor-α monoclonal antibody, 
and in two patients, there was complete regression of the lesions following immune reconstitution after 
allogenic haematopoietic stem cell transplant. Therefore, recovery of immune function might resolve both 
the unidentified infections and correct immune dysregulation.5 
Our paediatric case demonstrates a rare association of cutaneous LG with CHH. We conclude that EBV-
driven lymphoproliferative disorder should be considered when patients with CHH develop granulomatous 
lesions. EBER staining is essential in this scenario to exclude LG, as the histopathology of most of these 
granulomas can appear benign. 
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Learning points 
• CHH is an autosomal recessive disorder characterized by short stature, sparse hair and 
immunodeficiency due to mutations in the RMRP gene. 
• CHH has a wide spectrum of clinical manifestations.  
• Mortality is high, owing to recurrent infections and malignancies. 
• The extent of the immunodeficiency in CHH is highly variable, ranging from mild to severe, and can 
affect both T-cell and humoral immunity. 
• LG is a rare EBV-driven B-cell lymphoproliferative disorder primarily involving the lungs and usually 
occurs in middle-aged adults and rarely seen in childhood. 
• EBV-driven lymphoproliferative disorders should be considered during evaluation of patients with 
immunodeficiencies, and granulomatous inflammation and EBER staining is necessary to establish the 
diagnosis. 
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Figure 1 (a,b) Erythematous slightly purplish plaques and nodules with mild atrophy involving the nose, 
upper lips and chin; (c,d) worsening of the skin lesions despite chemotherapy, with extensive plaques 
involving the nose and extending to the cheeks, lips and the chin; (e,f) improvement of the skin lesions at 
(e) 4 and (f) 7 months following peripheral blood stem cell transplant . 
Figure 2 (a) Lung biopsy showed nodules that were partially necrotic and composed of dense aggregates 
of large atypical lymphoid cells (haematoxylin and eosin, original magnification × ???). (b) In situ 
hybridization with an Epstein–Barr virus (EBV) early RNA (EBER) probe, showing that almost all the cells 
were positive for EBV. 
Figure 3 (a–c) Skin biopsy from a chin plaque showing (a) dense and diffuse chronic inflammatory infiltrate 
of reticular dermis composed of nonatypical lymphocytes, histiocytes and scattered larger lymphoid cells; 
(b) focal localization of epithelioid granulomas; (c)  angiocentric and angioinvasive infiltrate. Haematoxylin 
and eosin, original magnification (a) × ???; (b) × ???; (c) × ???. (d) In situ hybridization with tan Epstein–
Barr virus (EBV) early RNA (EBER) probe, showing occasional EBV-positive cells. 
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